Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors
The DOI matches its Crossref record.
Abstract
Some studies suggest that estrogen acts on bone by decreasing the production of interleukin-6 (IL-6), a cytokine that increases bone resorption, by osteoblasts or bone marrow cells. However, other studies have not confirmed this, possibly because of a low and variable number of estrogen receptors (ER) in the model systems used. Thus, we employed a recently developed human fetal osteoblast cell line with high levels of ER. Treatment (n = 4 experiments) with 0.01 to 10 nM of 17β-estradiol had no effect on the constitutive production of IL-6. However, stimulated production, induced by treatment with IL-1β plus tumor necrosis factor-α (TNF-α), was reduced in a dose-dependent manner to 74 + 3% (mean + SEM) of control (p < 0.01). This response was blocked by cotreatment with the type II antiestrogen ICI 182,780. Treatment with hydrocortisone (1 μM), a known inhibitor of IL-6 production in many cell types, reduced IL-6 production to 17 + 1% of control (p < 0.001). As assessed by Northern analysis, treatment (n = 3 experiments) with 0.01-10 nM of 17β-estradiol decreased steady-state levels of IL-6 mRNA in a dose-dependent manner. These data support the hypothesis that at least part of the antiresorptive action of estrogen in humans is mediated by decreased production of IL-6 by osteoblastic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 33
- Heancy, 1978, Menopausal changes in bone remodelling., J Lab Clin Med, 92, 964
- Eriksen, 1988, Evidence of estrogen receptors in normal human osteoblast-like cells., Science, 241, 84, 10.1126/science.3388021 · DOI · Paper page
- Keeting, 1991, Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells., J Bone Miner Res, 6, 297, 10.1002/jbmr.5650060312 · DOI
- Manolagas, 1995, Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis., New Engl J Med, 332, 305, 10.1056/NEJM199502023320506 · DOI · Paper page
- Girasole, 1992, 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens., J Clin Invest, 89, 883, 10.1172/JCI115668 · DOI · Paper page
- Passeri, 1993, Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal., Endocrinology, 133, 822, 10.1210/endo.133.2.8393776 · doi:10.1210/endo.133.2.8393776 · Paper page
- Pottratz, 1994, 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism., J Clin Invest, 93, 944, 10.1172/JCI117100 · DOI · Paper page
- Ray, 1994, Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor., J Biol Chem, 269, 12940, 10.1016/S0021-9258(18)99966-7 · DOI · Paper page
- Rickard, 1992, Oestradiol inhibits the release of tumor necrosis factor but not interleukin 6 from adult human osteoblasts in vitro., Osteoporos Int, 2, 94, 10.1007/BF01623843 · DOI
- Chaudhary, 1992, Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: Lack of regulation by 17β-estradiol., Endocrinology, 130, 2528, 10.1210/endo.130.5.1572280 · doi:10.1210/endo.130.5.1572280 · Paper page
- Rifas, 1995, Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids., Endocrinology, 136, 4056, 10.1210/endo.136.9.7649114 · doi:10.1210/endo.136.9.7649114 · Paper page
- Jilka, 1992, Increased osteoclast development after estrogen loss: mediation by interleukin-6., Science, 257, 88, 10.1126/science.1621100 · DOI · Paper page
- Kitazawa, 1994, Interleukin-I receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice., J Clin Invest, 94, 2397, 10.1172/JCI117606 · DOI · Paper page
- Bellido, 1993, Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3., Endocrinology, 133, 553, 10.1210/endo.133.2.8393768 · DOI
- Davis, 1994, Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines., J Bone Miner Res, 9, 983, 10.1002/jbmr.5650090705 · DOI · Paper page
- Ernst, 1991, Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element., Mol Endocrinol, 5, 1597, 10.1210/mend-5-11-1597 · doi:10.1210/mend-5-11-1597
- Migliaccio, 1992, Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor., Endocrinology, 130, 2617, 10.1210/endo.130.5.1572285 · DOI
- Harris, 1995, Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene., J Cell Biochem, 59, 193, 10.1002/jcb.240590209 · DOI
- Harris, 1995, Development and characterization of a conditionally immortalized human fetal osteoblastic cell line., J Bone Miner Res, 10, 178, 10.1002/jbmr.5650100203 · DOI · Paper page
- Chomezynski, 1987, Single-step method of RNA isolation and by acid guanidinium thiocyanate-phenol-chloroform extraction., Anal Biochem, 162, 156
- Alderson, 1991, Interleukin-7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes., J Exp Med, 173, 923, 10.1084/jem.173.4.923 · DOI · Paper page
- Kassem, 1993, Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro., Calcif Tissue Int, 52, 222, 10.1007/BF00298723 · DOI · Paper page
- Poli, 1994, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion., EMBO J, 13, 1189, 10.1002/j.1460-2075.1994.tb06368.x · DOI · Paper page
- Marie, 1993, In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation., J Clin Endocrinol Metabol, 77, 824
- McKane, 1994, Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women., J Bone Miner Res, 9, 1313, 10.1002/jbmr.5650090821 · DOI · Paper page
- Khosla, 1994, Circulating cytokine levels in osteoporotic and normal women., J Clin Endocrinol Metabol, 79, 707
- Horowitz, 1993, Cytokines and estrogen in bone: antiosteoporotic effects., Science, 260, 626, 10.1126/science.8480174 · DOI · Paper page
- Pacifici, 1992, Is there a causal role for IL-1 in postmenopausal bone loss?., Calcif Tissue Int, 50, 295, 10.1007/BF00301625 · DOI
- Roodman, 1992, Interleukin-6: An osteotropic factor?, J Bone Miner Res, 7, 475, 10.1002/jbmr.5650070502 · DOI · Paper page
- Oursler, 1991, Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone., Endocrinology, 129, 3313, 10.1210/endo-129-6-3313 · DOI · Paper page
- Oreffo, 1990, Inhibitory effects of the bonederived growth factors osteoinductive factor and transforming growth factor-β on isolated osteoclasts., Endocrinology, 126, 3069, 10.1210/endo-126-6-3069 · DOI
- Oursler, 1994, Human giant cell tumours of the bone (osteoclastomas) are estrogen target cells., Proc Natl Acad Sci USA, 91, 5227, 10.1073/pnas.91.12.5227 · DOI · Paper page
- Oursler, 1941, Avian osteoclasts as estrogen target cells., Proc Natl Acad Sci USA, 88, 6613, 10.1073/pnas.88.15.6613 · DOI · Paper page
Cited by
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology
Nanes, M. S. (2003) · Gene · doi:10.1016/s0378-1119(03)00841-2 · Cited by 440
Cytokines, bone remodeling, and estrogen deficiency: a 1998 update
JILKA, R. (1998) · Bone · doi:10.1016/s8756-3282(98)00077-5 · Cited by 255
Metadata
- Authors
- Kassem, M., Harris, S. A., Spelsberg, T. C., & Riggs, B. L.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-02-01
- Volume
- 11
- Issue
- 2
- Pages
- 193-199
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2097339826
- Cited by
- 136
- References
- 0
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- National Institute of Health (AG-04875)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. https://app.cochat.ai/papers/10.1002/jbmr.5650110208
- The paper
- Kassem, M., Harris, S. A., Spelsberg, T. C., & Riggs, B. L. (1996). Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650110208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.